cysteine and Carcinoma, Lewis Lung

cysteine has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, C; Kang, DH; Kang, SW; Kim, J; Koh, GY; Koh, YJ; Lee, DJ; Lee, JY; Lee, KW; Lee, SH; Park, YS; Yu, DY	1

Other Studies

1 other study(ies) available for cysteine and Carcinoma, Lewis Lung

Article	Year
Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Molecular cell, 2011, Nov-18, Volume: 44, Issue:4 Topics: Animals; Antioxidants; Aorta; Carcinoma, Lewis Lung; Caveolae; Cysteine; Disulfides; Endothelial Cells; Endothelium, Vascular; Gene Silencing; Humans; Hydrogen Peroxide; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Neoplasm Transplantation; Neovascularization, Pathologic; Oxidation-Reduction; Peroxiredoxins; Protein Binding; Protein Structure, Tertiary; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2	2011

Article

Year

Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells.

Molecular cell, 2011, Nov-18, Volume: 44, Issue:4

Topics: Animals; Antioxidants; Aorta; Carcinoma, Lewis Lung; Caveolae; Cysteine; Disulfides; Endothelial Cells; Endothelium, Vascular; Gene Silencing; Humans; Hydrogen Peroxide; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Neoplasm Transplantation; Neovascularization, Pathologic; Oxidation-Reduction; Peroxiredoxins; Protein Binding; Protein Structure, Tertiary; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2

2011